相关临床试验
2
2 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
1
50.0%
尚未招募
1
50.0%
暂无批准数据
- Flinders University researchers received $9 million from the NHMRC 2026 Centres of Research Excellence grants, split equally across three projects addressing urgent health challenges. - Professor Raymond Chan will lead a $3 million Centre to improve holistic, value-based survivorship care for more than 1.6 million Australians living with cancer. - Associate Professor Courtney Ryder's STRONG Centre will advance Indigenous-led injury prevention and care for Aboriginal and Torres Strait Islander communities, where injury is the third leading cause of death. - Professor James Smith's WellMen Centre will develop strategies to address the mental health and wellbeing crisis among Australian boys and men in schools, sports clubs, and online settings.
- The RESTORE trial demonstrates that cognitive functional therapy (CFT) produces clinically important reductions in chronic low back pain and activity limitations that persist for three years. - CFT, delivered through seven sessions by specially trained physiotherapists, significantly outperformed usual care in reducing both pain intensity and physical activity limitations. - This represents the first large, high-quality study investigating long-term CFT outcomes, offering potential to markedly reduce the global burden of chronic back pain. - The biopsychosocial approach addresses physical, psychological and social factors while empowering patients with self-management skills and confidence to move.
- The National Health and Medical Research Council (NHMRC) has awarded $8.3 million to University of Sydney researchers for clinical trials addressing critical gaps in cancer and addiction treatment. - Four key projects received funding, including innovative approaches to skin cancer diagnosis, lung cancer treatment, cancer immunotherapy risk assessment, and cannabidiol for alcohol use disorder. - The funded research aims to translate scientific discoveries into implementable clinical solutions that will significantly improve patient outcomes and healthcare practices across Australia.
- Australian researchers at the University of Queensland are developing innovative iron-based nanoparticles to enhance immunotherapy effectiveness against triple-negative breast cancer, which lacks proteins targeted by conventional treatments. - The "nano-adjuvants," supported by a $3 million NHMRC grant, are designed to boost T-cell activity within the tumor microenvironment, potentially transforming treatment outcomes for one of the most aggressive forms of breast cancer. - This five-year research project aims to bridge a critical treatment gap for TNBC, which accounts for 30% of breast cancer deaths despite representing only 10-15% of cases, with potential applications for other hard-to-treat cancers like ovarian cancer.
- Australia and the UK are jointly funding clinical trials with A$30 million to address significant unmet clinical needs. - The funding supports platform trials that simultaneously assess multiple interventions for serious health conditions. - The collaboration aims to leverage global talent and accelerate the development of new therapies in areas with limited treatment options. - Priority areas for the joint research include cancers, stroke, neurodegenerative diseases, and obesity.
